Canada markets closed

Acura Pharmaceuticals, Inc. (ACUR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0041+0.0011 (+36.67%)
At close: 03:39PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
Total Revenue
1,563
1,563
3,570
Operating Expenses
Research Development
1,524
1,524
1,781
Selling General and Administrative
1,253
1,253
2,547
Total Operating Expenses
2,777
2,777
4,328
Operating Income or Loss
-1,214
-1,214
-758
Interest Expense
200
200
450
Total Other Income/Expenses Net
535
535
-
Income Before Tax
-879
-879
-1,208
Income Tax Expense
0
0
0
Income from Continuing Operations
-879
-879
-1,208
Net Income
-879
-879
-1,208
Net Income available to common shareholders
-879
-879
-1,208
Basic EPS
-0.04
-0.02
-0.04
Diluted EPS
-0.04
-0.02
-0.04
Basic Average Shares
32,320
56,801
32,320
Diluted Average Shares
32,320
56,801
32,320